Increased paclitaxel recovery from Taxus baccata vascular stem cells using novel in situ product recovery approaches
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Santoyo-Garcia, Jorge H.
- dc.contributor.author Valdivia-Cabrera, Marissa
- dc.contributor.author Ochoa-Villarreal, Marisol
- dc.contributor.author Casasola-Zamora, Samuel
- dc.contributor.author Ripoll, Magdalena
- dc.contributor.author Escrich Montañana, Ainoa
- dc.contributor.author Moyano Claramunt, Elisabet
- dc.contributor.author Betancor, Lorena
- dc.contributor.author Halliday, Karen J.
- dc.contributor.author Loake, Gary J.
- dc.contributor.author Rios-Solis, Leonardo
- dc.date.accessioned 2023-11-30T07:32:48Z
- dc.date.available 2023-11-30T07:32:48Z
- dc.date.issued 2023
- dc.description.abstract In this study, several approaches were tested to optimise the production and recovery of the widely used anticancer drug Taxol® (paclitaxel) from culturable vascular stem cells (VSCs) of Taxus baccata, which is currently used as a successful cell line for paclitaxel production. An in situ product recovery (ISPR) technique was employed, which involved combining three commercial macro-porous resin beads (HP-20, XAD7HP and HP-2MG) with batch and semi-continuous cultivations of the T. baccata VSCs after adding methyl jasmonate (Me-JA) as an elicitor. The optimal resin combination resulted in 234 ± 23 mg of paclitaxel per kg of fresh-weight cells, indicating a 13-fold improved yield compared to the control (with no resins) in batch cultivation. This resin treatment was further studied to evaluate the resins’ removal capacity of reactive oxygen species (ROS), which can cause poor cell growth or reduce product synthesis. It was observed that the ISPR cultivations had fourfold less intracellular ROS concentration than that of the control; thus, a reduced ROS concentration established by the resin contributed to increased paclitaxel yield, contrary to previous studies. These paclitaxel yields are the highest reported to date using VSCs, and this scalable production method could be applied for a diverse range of similar compounds utilising plant cell culture.
- dc.format.mimetype application/pdf
- dc.identifier.citation Santoyo-Garcia JH, Valdivia-Cabrera M, Ochoa-Villarreal M, Casasola-Zamora S, Ripoll M, Escrich A, Moyano E, Betancor L, Halliday KJ, Loake GJ, Rios-Solia L. Increased paclitaxel recovery from Taxus baccata vascular stem cells using novel in situ product recovery approaches. Bioresour Bioprocess. 2023;10(68). DOI: 10.1186/s40643-023-00687-8
- dc.identifier.doi http://dx.doi.org/10.1186/s40643-023-00687-8
- dc.identifier.issn 2197-4365
- dc.identifier.uri http://hdl.handle.net/10230/58415
- dc.language.iso eng
- dc.publisher Springer
- dc.relation.ispartof Bioresour Bioprocess. 2023;10(68)
- dc.rights © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Paclitaxel
- dc.subject.keyword In situ product recovery
- dc.subject.keyword Vascular stem cells
- dc.subject.keyword Taxus baccata
- dc.subject.keyword Reactive oxygen species
- dc.title Increased paclitaxel recovery from Taxus baccata vascular stem cells using novel in situ product recovery approaches
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion